Bladder Cancer
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
April 5, 2024
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
April 5, 2024
Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer.
April 5, 2024
Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.
April 5, 2024
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
April 5, 2024
Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer.
April 4, 2024
NPEPPS Is a Druggable Driver of Platinum Resistance.
April 4, 2024
Mechanism of action of nadofaragene firadenovec-vncg.
April 3, 2024
Association of household net worth with healthcare costs after radical cystectomy using real-world data.
April 2, 2024
Telemedicine for Multidisciplinary Urologic Cancer Care: A Prospective Single Institution Study.
April 1, 2024
A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer.
March 31, 2024